Searched for
CARDIAC STENTS
Cipla, Alkem Laboratories in final lap to buy SMTPromoters of SMT—the Kotadia family— plan to keep a minority stake after the transaction that would see other shareholders also divest thei...
Operation buyout: KKR, TPG, and other PE firms eye purchase of India's largest cardiac stent maker SMTMorgan Stanley PE Asia and Samara Capital collectively own 49% of the company while Kotak Pre IPO Opportunities Fund holds 6%. The Kotadias...
Delhi High Court seeks Centre's stand on plea on sale of coronary stentsThe petitioner, an advocate, said in his plea that currently cardiac stents are allowed to be manufactured, imported and sold "without or w...
Stent maker Sahajanand to sell 30% stake, eyes $300 mn valuationEstablished in 1998, SMT develops and manufactures cardiac products that are sold in 75 countries. Its portfolio includes coronary stents (...
Surgical strike! Prices of drug eluting stents cutCoronary stents are wire mesh tubes inserted into coronary arteries to clear blockages and prevent heart attacks.
Drug eluting stents expected to get cheaperThe maximum price that patients should pay for drug eluting, bioresorbable vascular and biodegradable coronary stents was reduced to Rs 27,...
Price cap on cardiac stents stifling innovation, harming patients: ManufacturersThe industry leaders demanded the expansion of the National List of Essential Medicines (NLEM) board evaluating the price-capping issue by ...
Focus shifts to expensive pacemakers, lenses, cathetersAfter the capping of cardiac stent prices, the Rajya Sabha petitions committee has turned its attention to overpricing of other medical dev...
Government to act against firms creating artificial shortage of stentsThere are reports of shortages of stents in hospitals after the government reduced their prices by up to 85 per cent by capping rates of ba...
Heart of the matter: Coronary stents get cheaper by up to 85%The average MRP for BMS was Rs 45,000 and for DES, it was Rs 1.21 lakh. The govt has asked companies to change the MRP of existing stock.
NPPA proposes to slash cardiac stent prices by 50%The body has proposed that ceiling prices of drug-eluting stents (DES) be fixed at rates ranging between Rs21,881 to Rs67,272—less than 50%...
Indian cardiac stents as expensive as imports: MNC associationIndian stents are not drastically cheaper to imported stents, says the Medical Technology Association of India
Cardiac stent prices dropped but patients charged high : IMS StudyThe report, coming in the backdrop of the government's moves to control prices of stents and other such medical devices.
Orthopedic implants may get up to 50 per cent cheaper over suggested price capsThe National Health Systems Resource Centre has suggested price caps in a report to drug pricing regulator National Pharmaceutical Pricing ...
Capping cardiac stent prices gets NHSRC backingThe final parameters to fix prices of stents will be based on the findings in the NHSRC report and the price lists submitted by manufacture...
Surat captures 30% share of cardiac stents market in India, becomes largest manufacturerSurat, famed for its Rs 90,000 crore diamond industry, has emerged as the biggest manufacturer of cardiac stents in India.
Maharashtra FDA writes to National Pharmaceutical Pricing Authority to regulate prices of stentsThe Maharashtra FDA has found that the companies that import cardiac stents inflate the Maximum Retail Price (MRP) of the stents during imp...